Skip to main content

ORIGINAL RESEARCH article

Front. Stroke
Sec. Stroke in the Young
Volume 3 - 2024 | doi: 10.3389/fstro.2024.1444718
This article is part of the Research Topic Prevention of Stroke and Vascular Cognitive Decline in the Pediatric Population View all 6 articles

Identifying Strokes in Nigerian Children with Sickle Cell Disease as Part of Clinical Trials: Training Curriculum for Healthcare Professionals in Low-Income Settings

Provisionally accepted
  • 1 Vanderbilt University Medical Center, Nashville, United States
  • 2 Barau Dikko Teaching Hospital, Kaduna, Nigeria
  • 3 Kaduna State University, Kaduna, Nigeria
  • 4 Department of Developmental Neurosciences, Great Ormond Street Institute of Child Health, Faculty of Population Health Sciences, University College London, London, England, United Kingdom
  • 5 Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • 6 Rodeghier Consulting, Chicago, Illinois, United States

The final, formatted version of the article will be published soon.

    Nigeria has the highest proportion of children with sickle cell anemia (SCA) globally; without transcranial Doppler screening and ongoing treatment (regular blood transfusions or hydroxyurea therapy), 10% will have a stroke in childhood. In low-resource settings, training to recognize and prevent strokes in children with SCA is vital. A sustainable Sickle Cell Disease Stroke Prevention Teams program was established, as part of clinical trials, to address the need for stroke care in northern Nigeria. We describe our health professional stroke training curriculum and specific application to detect strokes in clinical trials in low-resource settings.Methods: Children aged 5-12 and 2-16 years with SCA in northern Nigeria were enrolled in the SPRING and SPRINT primary and secondary stroke prevention trials, respectively. The primary outcome measure in both trials was a clinical stroke based on the World Health Organization definition. Non-neurologist physicians were trained in-person and via video lectures regarding stroke recognition, performing neurological examinations using the adapted Pediatric NIH Stroke Scale, and acute stroke care. Central stroke adjudicators, two pediatric neurologists, reviewed the case report forms and recorded videos of the neurological examinations.Results: Six physicians completed the curriculum at three sites and were certified to detect strokes. Of 20 children with suspected stroke, 8 and 11 children had acute initial or acute recurrent strokes confirmed in the SPRING (N=220) and SPRINT (N=101) trials, respectively. The concordance rate between local stroke diagnoses and the central stroke adjudication process was 95% (19 of 20). One child presented with non-specific symptoms and hypertonia and was mislabeled locally as an acute stroke.Discussion: A curriculum to train healthcare providers in pediatric acute stroke recognition and care in a low-resource setting is feasible and sustainable. We successfully identified strategies for task shifting from a single pediatric neurologist in the region to multiple non-neurologist physicians.

    Keywords: Stroke prevention, Children, Sickle cell anemia, Low-resource setting, Nigeria; Sub-Saharan Africa

    Received: 06 Jun 2024; Accepted: 25 Nov 2024.

    Copyright: © 2024 Ghafuri, Bello-Manga, Kirkham, Ciobanu, Trevathan, Rodeghier, DeBaun and Jordan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Lori Jordan, Vanderbilt University Medical Center, Nashville, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.